Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: kendall harmon who wrote (98603)	5/19/2000 6:42:00 PM
From: Jenna	Read Replies (1) \| Respond to of 120523

HH used to like this stock but the last sentence about the overreaction and 'long time financial prospect are still strong' can be cut and pasted to a couple of hundred stocks. HH will be vying for institutional interest in a market where it disappointed and it was overpriced to begin with. HH trades at a 84% Premium PE Multiple of 28.9 X, vs. the 15.7 X average multiple at which the Medical Services SubIndustry is priced. But for a daytrade it could be okay. Better stocks have not proven themselves either. PME looks interesting in that sector with a 120.00 % earning surprise last quarter (a resounding $0.1 versus the -(0.04) expected, and 115% EPS growth predicted for this fiscal year. Other strong stocks which have not disappointed like CIEN, NTAP, SCMR are down and looking like more appetizing bets. HH looks like another possible 'dead cat bounce' in a market that is now full of dead cats. Bounces are rare, lasting only mosquito years, Dead Cats are in abundance.